|
1
|
Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.
|
Cancer Res
|
2004
|
5.13
|
|
2
|
Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.
|
Prostate
|
2003
|
3.44
|
|
3
|
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
|
Cancer Res
|
2005
|
2.14
|
|
4
|
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
|
Nature
|
2012
|
2.11
|
|
5
|
Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing.
|
Proc Natl Acad Sci U S A
|
2011
|
1.94
|
|
6
|
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
|
Cancer Res
|
2006
|
1.90
|
|
7
|
Hypoxic adipocytes pattern early heterotopic bone formation.
|
Am J Pathol
|
2007
|
1.62
|
|
8
|
Cancer-related axonogenesis and neurogenesis in prostate cancer.
|
Clin Cancer Res
|
2008
|
1.56
|
|
9
|
Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.
|
Proc Natl Acad Sci U S A
|
2013
|
1.43
|
|
10
|
Relaxin promotes prostate cancer progression.
|
Clin Cancer Res
|
2007
|
1.34
|
|
11
|
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
|
Cancer Res
|
2011
|
1.32
|
|
12
|
SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.
|
J Biol Chem
|
2010
|
1.29
|
|
13
|
Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
|
Neoplasia
|
2008
|
1.26
|
|
14
|
RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer.
|
Cancer Res
|
2004
|
1.25
|
|
15
|
Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women.
|
Cancer Res
|
2006
|
1.24
|
|
16
|
Common structural and epigenetic changes in the genome of castration-resistant prostate cancer.
|
Cancer Res
|
2011
|
1.21
|
|
17
|
Notch and TGFβ form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity.
|
Cell Stem Cell
|
2012
|
1.16
|
|
18
|
Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.
|
Int J Cancer
|
2008
|
1.15
|
|
19
|
FGFR1 is essential for prostate cancer progression and metastasis.
|
Cancer Res
|
2013
|
1.14
|
|
20
|
Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
|
J Urol
|
2010
|
1.07
|
|
21
|
INPP4B: the new kid on the PI3K block.
|
Oncotarget
|
2011
|
1.07
|
|
22
|
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
|
Clin Cancer Res
|
2011
|
1.00
|
|
23
|
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.
|
Am J Pathol
|
2010
|
0.98
|
|
24
|
GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
|
Cancer Res
|
2011
|
0.98
|
|
25
|
The role of caveolin-1 in androgen insensitive prostate cancer.
|
J Urol
|
2002
|
0.97
|
|
26
|
Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
|
Cancer Res
|
2003
|
0.96
|
|
27
|
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.
|
J Mol Diagn
|
2012
|
0.96
|
|
28
|
Activation of Wnt signaling by chemically induced dimerization of LRP5 disrupts cellular homeostasis.
|
PLoS One
|
2012
|
0.95
|
|
29
|
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
|
Endocr Relat Cancer
|
2010
|
0.95
|
|
30
|
Detection of recurrent rearrangement breakpoints from copy number data.
|
BMC Bioinformatics
|
2011
|
0.94
|
|
31
|
Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX.
|
J Clin Virol
|
2009
|
0.90
|
|
32
|
FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stroma.
|
Cancer Res
|
2013
|
0.89
|
|
33
|
Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk.
|
Prostate
|
2011
|
0.86
|
|
34
|
Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis.
|
J Clin Invest
|
2015
|
0.86
|
|
35
|
Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.
|
Clin Cancer Res
|
2008
|
0.86
|
|
36
|
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2.
|
Mol Oncol
|
2012
|
0.86
|
|
37
|
SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.
|
Mol Endocrinol
|
2013
|
0.83
|
|
38
|
ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.
|
Mol Cancer Res
|
2013
|
0.82
|
|
39
|
ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC).
|
PLoS One
|
2013
|
0.79
|
|
40
|
Relaxin/RXFP1 signaling in prostate cancer progression.
|
Ann N Y Acad Sci
|
2009
|
0.79
|
|
41
|
Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
|
Horm Cancer
|
2015
|
0.77
|
|
42
|
The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.
|
Endocrinology
|
2014
|
0.77
|
|
43
|
Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
|
J Clin Invest
|
2016
|
0.76
|
|
44
|
Glutathione S-transferase pi is upregulated in the stromal compartment of hormone independent prostate cancer.
|
Prostate
|
2003
|
0.75
|